Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Depomed Inc

Market Cap 152M 132M 122M 115M 215M 14.31B 216M 1.45B 564M 7.05B 570M 558M 24.45B P/E 2026 *
-13.1x
P/E 2027 * 40.5x
Enterprise Value 152M 132M 122M 115M 215M 14.31B 216M 1.45B 564M 7.05B 570M 558M 24.45B EV / Sales 2026 *
1.3x
EV / Sales 2027 * 1.2x
Free-Float
98.03%
Yield 2026 *
-
Yield 2027 * -
Director TitleAgeSince
Director/Board Member - 16/06/2026
Director/Board Member 26 16/06/2026
Change 5-day change 1-year change 3-year change Capi.($)
-9.45%+3.54% - - 152M
-1.21%-5.37%+39.94%+145.38% 980B
-2.48%-4.17%+51.52%+39.07% 550B
-2.14%-3.68%+16.71%+56.15% 382B
-2.47%+0.25%+25.86%+16.53% 317B
+1.34%-1.01%+26.29%+14.43% 270B
+1.21%-2.15%+25.47%+31.49% 269B
+5.09%+2.42%-39.76%-45.66% 191B
-1.19%-4.65%+16.56%+47.00% 182B
-1.35%-1.68%+14.59%+56.94% 154B
Average -1.26%-2.68%+19.69%+40.15% 366B
Weighted average by Cap. -0.89%-3.38%+28.44%+64.23%

Financials

2026 *2027 *
Net sales 117M 102M 93.73M 88.16M 165M 11B 166M 1.12B 433M 5.42B 438M 429M 18.79B 127M 110M 102M 95.66M 179M 11.93B 180M 1.21B 470M 5.88B 475M 465M 20.38B
Net income -11.5M -10.02M -9.24M -8.69M -16.25M -1.08B -16.37M -110M -42.68M -534M -43.17M -42.24M -1.85B 4.35M 3.79M 3.5M 3.29M 6.15M 410M 6.2M 41.61M 16.16M 202M 16.34M 15.99M 701M
Net Debt - -
Logo Depomed Inc
Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!